日本无码

Feature Channels: Infectious Diseases

Filters close
Released: 23-May-2024 9:05 AM EDT
Penn Researchers Develop Experimental mRNA Avian Flu Vaccine
Perelman School of Medicine at the University of Pennsylvania

An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in preclinical models. The vaccine could potentially help manage the outbreak of the H5N1 virus currently circulating in birds and cattle in the United States, and prevent human infections with the virus.

21-May-2024 6:05 AM EDT
Research reveals more people died from hot or cold weather conditions than COVID-19 in parts of UK
University of Bristol

Research has highlighted how weather extremes worsened by climate change are now a major national public health threat.

日本无码:Video Embedded advancements-in-pediatric-respiratory-medicine-insights-from-leading-researchers
VIDEO
13-May-2024 9:40 AM EDT
VIDEO and TRANSCRIPT: RSV Risk And Undertreated Asthma: Expert Panel Q&A
News

Doctors with the American Thoracic Society will discuss new research about the potential effect of estrogen on hypertension for women in menopause, and the link between hormone replacement and breast cancer risk. How can patients and doctors weigh the risks and benefits and decide whether or not estrogen is right for them?

13-May-2024 9:00 AM EDT
New Tool May Help Prioritize High-Risk Infants for RSV Immunization
American Thoracic Society (ATS)

Pediatric Impact of COVID-19 and Other Respiratory Infections Clinical Prediction Tool for Prioritizing Respiratory Syncytial Virus Prevention Products for High-Risk Infants During Current Limited Availability of Nirsevimab in the United States

日本无码: Study that empowers traditional health practitioners to test for HIV expands in rural South Africa
Released: 21-May-2024 3:05 AM EDT
Study that empowers traditional health practitioners to test for HIV expands in rural South Africa
University of the Witwatersrand, Johannesburg

A National Institutes of Health five-year, $2.8 million grant to Wits and Vanderbilt University will advance traditional health practitioner-initiated HIV testing.

Not for public release

This news release is embargoed until 20-May-2024 5:00 PM EDT Released to reporters: 14-May-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2024 5:00 PM EDT The 日本无码 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 20-May-2024 11:05 AM EDT
Is a Global Pandemic Prevention Pact Within Reach?
Harvard Medical School

The World Health Organization鈥檚 governing body is scheduled to meet on May 27 to discuss a critically needed plan for global pandemic preparedness.

日本无码: Not sure about vaccines? How public health messaging is framed makes a difference, new research reveals
Released: 20-May-2024 10:05 AM EDT
Not sure about vaccines? How public health messaging is framed makes a difference, new research reveals
Binghamton University, State University of New York

What鈥檚 the best way to communicate with a vaccine-hesitant person about a vaccine鈥檚 potential benefits? New research from Binghamton University, State University of New York found that a one-size-fits-all approach to communicating messages isn鈥檛 effective.

日本无码: Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Released: 17-May-2024 1:05 PM EDT
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Washington University in St. Louis

A study by researchers at Washington University School of Medicine in St. Louis has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes COVID-19, as well as related coronaviruses.

日本无码: Vivek%20Kumar%20with%20hydrogels-resize.jpg?itok=Ls_qh5Tc
Released: 17-May-2024 1:05 PM EDT
NJIT Engineers Muffle Invading Pathogens with a 'Molecular Mask'
New Jersey Institute of Technology (NJIT)

Vaccines remain the gold standard of protection against dangerous pathogens, but take considerable time and vast resources to develop. Rapidly mutating viruses such as SARS-CoV-2 can blunt their effectiveness and even render them obsolete.

   
日本无码: New Electrostatic Sampler Boosts Indoor Virus Detection Speed
Released: 16-May-2024 8:25 AM EDT
New Electrostatic Sampler Boosts Indoor Virus Detection Speed
Chinese Academy of Sciences

Researchers have developed a groundbreaking electrostatic air sampler that enhances the rapid monitoring of airborne influenza and coronavirus. The device, capable of high air flow rates, offers significant advancements in detecting viral presence in indoor environments through polymerase chain reaction (PCR) analysis.

   
Released: 15-May-2024 9:05 AM EDT
What Dog Owners Should Know About Leptospirosis
Tufts University

Leptospirosis is an illness caused by a bacteria called leptospira that can be present in soil and stagnant water. Rodents and other wildlife carry the bacteria and spread it through their urine. Both humans and dogs can become sick with leptospirosis, while cats are considered disease-resistant. For both people and dogs, the result of infection can range from mild to deadly serious.

   
日本无码: Social distancing plus vaccines prevented 800,000 COVID deaths - but at great cost
Released: 14-May-2024 2:05 PM EDT
Social distancing plus vaccines prevented 800,000 COVID deaths - but at great cost
University of Colorado Boulder

Changing people鈥檚 behavior until a vaccine could be developed prevented roughly 800,000 COVID-19 deaths in the U.S., according to new CU Boulder and UCLA research. But the authors stress that interventions like lockdowns and school closures came at great economic and social cost.

Released: 13-May-2024 3:05 PM EDT
Herpes cure with gene editing makes progress in laboratory studies
Fred Hutchinson Cancer Center

Researchers at Fred Hutch Cancer Center have found in pre-clinical studies that an experimental gene therapy for genital and oral herpes removed 90% or more of the infection and suppressed how much virus can be released from an infected individual, which suggests that the therapy would also reduce the spread of the virus.

Released: 13-May-2024 3:05 PM EDT
Texas Tech Researchers Help Confirm First Case of Avian Influenza Transmitted from Cow to Human
Texas Tech University

Researchers from the Biological Threat Response Laboratory played a critical role in testing for the virus.

Released: 13-May-2024 9:05 AM EDT
Negotiations for a Global Pandemic Agreement Extended
Wildlife Conservation Society

Member States of the World Health Organization (WHO) were due to converge on text for a global pandemic agreement during their ninth and final negotiating session in March; however, insufficient progress was made in those two weeks, in terms of finding consensus.

日本无码: 3i Symposium Inspires Interdisciplinary Insights in Immunology, Inflammation, and Infection
Released: 9-May-2024 5:05 PM EDT
3i Symposium Inspires Interdisciplinary Insights in Immunology, Inflammation, and Infection
University of Utah Health

Over 150 researchers from across the University of Utah gathered to form new connections and share groundbreaking research on topics from antibiotic resistance to autoimmune diseases.

   
日本无码: An Entirely New COVID-Related Syndrome
Released: 9-May-2024 12:05 PM EDT
An Entirely New COVID-Related Syndrome
University of California San Diego

A group of UC San Diego researchers, centered at UC San Diego's Institute for Network Medicine, teamed up with rheumatologists at the University of Leeds in the United Kingdom to solve a medical mystery.

Released: 9-May-2024 10:00 AM EDT
Shruti Mehta, Infectious Disease Epidemiologist, Named Chair of Johns Hopkins Bloomberg School of Public Health Epidemiology Department
Johns Hopkins Bloomberg School of Public Health

Shruti Mehta, PhD, MPH, has been named The Dr. Charles Armstrong Chair in Epidemiology and Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, effective June 1.

Released: 26-Apr-2024 12:05 PM EDT
Texas Biomed Researching Vaccines and Treatments for Highly Pathogenic Avian Influenza
Texas Biomedical Research Institute

Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.

Released: 26-Apr-2024 12:00 PM EDT
Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
World Journal of Stem Cells

Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection typically presents with fever and respiratory symptoms, which can progress to

25-Apr-2024 12:05 PM EDT
Undocumented Latinx patients got COVID-19 vaccine at same rate as U.S. citizens
University of California, Los Angeles (UCLA), Health Sciences

For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study found.

Released: 26-Apr-2024 10:05 AM EDT
New Tool Helps Identify Babies at High-Risk for RSV
Vanderbilt University Medical Center

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April), according to Vanderbilt University Medical Center (VUMC) research published in Open Forum Infectious Diseases and to be presented at the American Thoracic Society 2024 International Conference.

18-Apr-2024 4:05 PM EDT
Future Parents More Likely to Get RSV Vaccine When Pregnant if Aware That RSV Can Be a Serious Illness in Infants
Ann and Robert H. Lurie Children's Hospital of Chicago

A nationwide survey of people who were pregnant or trying to become pregnant found that overall 54 percent expressed interest in the RSV vaccine during pregnancy. Perceiving RSV as a serious illness in infants was the strongest predictor of likely vaccination during pregnancy. Likelihood to receive the RSV vaccine during pregnancy was also higher among parents with a child at home already. Findings were published in the journal Pediatrics.

日本无码: Vaccinologists Keith Klugman and Shabir Madhi awarded Sabin鈥檚 Prestigious Gold Medal
Released: 23-Apr-2024 3:05 AM EDT
Vaccinologists Keith Klugman and Shabir Madhi awarded Sabin鈥檚 Prestigious Gold Medal
University of the Witwatersrand, Johannesburg

The Sabin Vaccine Institute presented the Albert B. Sabin Gold Medal to physician-researchers Keith Klugman and Shabir Madhi.

Released: 22-Apr-2024 9:05 AM EDT
Rise seen in use of antibiotics for conditions they can鈥檛 treat 鈥 including COVID-19
Michigan Medicine - University of Michigan

America is going the wrong way when it comes to prescribing antibiotics, with 1 in 4 prescriptions going to patients who have conditions that the drugs won鈥檛 touch, a new study finds.

日本无码: From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic
Released: 15-Apr-2024 9:05 PM EDT
From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic
University of South Australia

New research has given insight into the resilience and recovery of businesses in two South Australian regions following a major bushfire event and disruptions caused by the COVID-19 pandemic.

Not for public release

This news release is embargoed until 15-Apr-2024 5:00 PM EDT Released to reporters: 9-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-Apr-2024 5:00 PM EDT The 日本无码 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

日本无码: Researchers resolve old mystery of how phages disarm pathogenic bacteria
Released: 15-Apr-2024 8:05 AM EDT
Researchers resolve old mystery of how phages disarm pathogenic bacteria
Texas A&M AgriLife

New study details long-sought mechanisms and structures

Released: 11-Apr-2024 4:05 PM EDT
MSU expert: what to know about avian influenza detections
Michigan State University

Although the current avian influenza outbreak began more than two years ago, detections have been made in recent weeks in cattle, cats and large commercial poultry flocks across the country and in Michigan.

Released: 9-Apr-2024 11:05 AM EDT
HealthTrackRx Appoints Leading Healthcare Expert Dr. Steven Goldberg as Chief Medical Officer
HealthTrackRx

HealthTrackRx, the nation's premier molecular diagnostic testing laboratory, today announced the appointment of Steven Goldberg, MD, MBA, as its Chief Medical Officer (CMO).

3-Apr-2024 2:05 PM EDT
A monoclonal antibody targeting the fusion glycoprotein spike protects against deadly Nipah virus
Uniformed Services University of the Health Sciences (USU)

The humanized monoclonal antibody known as hu1F5, which specifically binds to the fusion (F) glycoprotein of both Nipah virus and Hendra virus and prevents virus infection of cells (neutralizes) has now proven effective in protecting against the often fatal Nipah virus in animal studies.

日本无码: Testing environmental water to monitor COVID-19 spread in unsheltered encampments
29-Mar-2024 8:00 AM EDT
Testing environmental water to monitor COVID-19 spread in unsheltered encampments
American Chemical Society (ACS)

To better understand COVID-19鈥檚 spread during the pandemic, public health officials expanded wastewater surveillance. These efforts track SARS-CoV-2 levels and health risks among most people, but they miss people who live without shelter, a population particularly vulnerable to severe infection.

   
日本无码: UC San Diego Receives $6.7M to Develop Whole-Body Inflammation Imaging
Released: 1-Apr-2024 6:05 PM EDT
UC San Diego Receives $6.7M to Develop Whole-Body Inflammation Imaging
University of California San Diego

Researchers at UC San Diego have received new grants that will help develop full-body imaging techniques to detect inflammation, which is currently very difficult to visualize in the clinic.

Not for public release

This news release is embargoed until 1-Apr-2024 5:00 PM EDT Released to reporters: 27-Mar-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Apr-2024 5:00 PM EDT The 日本无码 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

日本无码: Hunting an Underground Epidemic
Released: 1-Apr-2024 2:05 PM EDT
Hunting an Underground Epidemic
University of Utah Health

Valley fever is a fungal respiratory infection that鈥檚 stealthily spreading through the soil and dust throughout the American West. An interdisciplinary research team is trying to map where the disease-causing fungus can survive and where it鈥檒l spread as the climate changes.

   
Released: 1-Apr-2024 1:05 PM EDT
Georgia Tech Researchers Develop More Broadly Protective Coronavirus Vaccine
Georgia Institute of Technology

Researchers at the Georgia Institute of Technology and the University of Wisconsin-Madison have developed a new vaccine that offers broad protection against not only SARS-CoV-2 variants, but also other bat sarbecoviruses.

日本无码: Cancer therapies show promise in combating tuberculosis
Released: 25-Mar-2024 3:05 PM EDT
Cancer therapies show promise in combating tuberculosis
University of Notre Dame

A study from the University of Notre Dame, Massachusetts General Hospital and the National Institutes of Health has identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery.

日本无码: Breakthrough antibiotic shows promise against obstinate mycobacterial infections
Released: 25-Mar-2024 3:05 AM EDT
Breakthrough antibiotic shows promise against obstinate mycobacterial infections
National University of Singapore (NUS)

A team of scientists led by Prof Guillermo Bazan from NUS Institute for Functional Intelligent Materials (I-FIM) has developed a novel antibiotic named COE-PNH2 that is capable of combating hard-to-treat mycobacterial lung infections.

   


close
5.11013